Developing resources and workforce for research on high-priority pathogens.
Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment Laboratory
['FUNDING_OTHER'] · UNIVERSITY OF MISSOURI-COLUMBIA · NIH-10910190
This study is all about making the University of Missouri's lab better at studying important germs, like those that cause COVID-19, so that researchers can find new treatments and keep everyone safer during outbreaks.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MISSOURI-COLUMBIA (nih funded) |
| Locations | 1 site (COLUMBIA, UNITED STATES) |
| Trial ID | NIH-10910190 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the capabilities of the University of Missouri's Regional Biocontainment Laboratory to study high-priority pathogens, including those related to COVID-19. It aims to improve research resources and workforce development, ensuring that researchers have access to state-of-the-art equipment and professional services. The laboratory collaborates with national networks to share knowledge and best practices, ultimately strengthening the nation's preparedness for infectious disease outbreaks. Patients may benefit indirectly through improved research outcomes and advancements in treatment options.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals affected by or at risk for infectious diseases, particularly those related to COVID-19.
Not a fit: Patients with non-infectious diseases or those not impacted by high-priority pathogens may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better preparedness and response strategies for infectious diseases, potentially improving patient outcomes during outbreaks.
How similar studies have performed: Other research initiatives focused on high-priority pathogens have shown success in enhancing preparedness and response strategies, indicating that this approach is both relevant and necessary.
Where this research is happening
COLUMBIA, UNITED STATES
- UNIVERSITY OF MISSOURI-COLUMBIA — COLUMBIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GRIFFITHS, ANTHONY — UNIVERSITY OF MISSOURI-COLUMBIA
- Study coordinator: GRIFFITHS, ANTHONY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.